Showing 3 results for McF-7 Cell Line
Volume 5, Issue 1 (7-2021)
Abstract
Abstract
Research Subject: Breast cancer is one of the most common cancer in the world with the highest mortality rate in women. Chemotherapy is the typical therapy for the cancer. However, it has side effects due to damage to healthy cells. Targeted drug delivery by nano carriers to the cancerous cells reduces the toxic side effects on normal cells. Serum albumin is a widely used drug carrier because of its availability, ease of preparation, and binding ability to various ligands. Attachment of iron oxide nanoparticles to albumin can control their distribution by applying an external magnetic field.
Research Approach: In this study, albumin nanoparticles attached to superparamagnetic iron oxide nanoparticles (SPIONs) were synthesized and loaded with 5-Fluorouracil (5-FU) anticancer drug by using the desolvation technique. The produced nanoparticles were characterized in terms of size, surface charge, and drug entrapment, by dynamic light scattering (DLS) and UV-Vis spectrophotometry. The cytotoxic effects of 5FU-loaded magnetic albumin nanoparticles and free 5FU on MCF7 cells were evaluated with the MTT assay. The internalization of nanoparticles in MCF-7 cells was confirmed by Prussian blue staining. In the end, the effects of nanoparticles on cell cycle and apoptosis were evaluated by flow cytometry using propidium iodide.
Main Results: The mean particle size and zeta potential of 5FU loaded albumin nanoparticles and albumin magnetic nanoparticles were 220 nm, -25.8 mV, and 221 nm, -28 mV respectively. Drug entrapment efficiency and drug loading efficiency were also, 20%, 1%, and 15.8%, and 0.06% for albumin nanoparticles and magnetic albumin nanoparticles in turn. The drug-loaded magnetic albumin nanoparticles showed higher cytotoxicity than the free drug on MCF-7 cells. The flow cytometry cell cycle analysis showed more cytotoxicity of albumin nanoparticles in comparison with other groups. According to these results, it can be said that 5-FU loaded magnetic albumin nanoparticles were more effective and deserve further studies in the cancer treatment.
Keywords: Albumin magnetic nanoparticles, 5-fluorouracil, targeted drug delivery, MCF-7 cell line
H. Danafar, A. R. Nomani, M. Sadeghizadeh,
Volume 10, Issue 3 (9-2019)
Abstract
Nanotechnology is currently one of the promising approaches for cancer diagnosis and treatment. Among different materials that so far have been used for drug delivery, the systems based on the polymers are more attractive, due to their simple manufacturing processes and diversity in polymer functionalization and modification methods. Polyethyleneglycol (PEG) and polycaprolactone (PCL) are two FDA approved and biocompatible synthetic polymers which frequently have been used in the pharmaceutical industry. Apart from the delivery carriers, the active ingredient’s safety is also very challenging in case of cancer therapeutics. The chemotherapy agent’s side effects are one of the main patients’ death in many cancers. The naturally extracted curcumin is one of the most interesting anti-cancer agents with a proven selective effect on the cancerous cells which results in minimum side effects during the treatment. Curcumin has been tested as the main agent or in combination therapy of various cancers. Numerous studies have shown the safety and efficacy of curcumin at different administered doses. However, the main obstacle in the application of curcumin is its low aqueous solubility and low and variable bioavailability after administration. For that, in this study, we tried to enhance the solubility of curcumin using a novel diblock copolymer of PEG-PCL nanoparticulate system. At first, the PEG-PCL copolymer was synthesized and then characterized by GPC, FTIR, and H NMR methods. After that, curcumin was loaded in the micellar structure of PEG-PCL at an optimized encapsulation approach and then the toxicity of the prepared nanoparticles was assessed in MCF-7 cell culture. The results showed that the prepared nanoparticles could efficiently entrap the hydrophobic molecules of curcumin, improve its solubility and increase in vitro activity against cancer cell line.
Mohaddeseh Baravordeh, Hossein Ghafouri, Asadollah Mohammadi, Sevda Zarei,
Volume 12, Issue 2 (1-2022)
Abstract
Aim: During the uncontrolled development of cells in the body, a subset of neoplasms or tumors is formed, the abnormal proliferation of these cells leads to the formation of a mass and eventually cancer. This mass can spread throughout the body. Thus, inhibiting the abnormal growth of cancer cells will have a significant effect on preventing the spread of cancerous tumors and improving the disease. Therefore, in the present study, a new sulfonamide derivative was designed and synthesized (HB20) and its anti-cancer effects on human breast cancer cell line (MCF-7) were investigated.
Materials and Methods: For the synthesis of a sulfonamide derivative (HB20), dcriptiazonium salt was first made using a sulfamethoxazole base compound and then combined with a pyrimidine coupling agent. Concentrations of a new synthetic compound (HB20) against Cells (MCF-7) were used. MTT assay was also performed to measure survival and cell proliferation.
Results: The synthesized compound structure was confirmed by spectral analysis, such as FT- IR, and NMR. Also, Survival in MCF-7 cells treated with a synthetic compound (HB20) was significantly reduced compared to the control group (untreated). HB20 inhibits the proliferation of MCF-7 cancer cells with an IC50 value of 75/23 μg/ml.
Conclusion: The new sulfonamide derivative (HB20) has the potential to inhibit proliferation and anti-cancer properties in the cell line (MCF-7).
